Oncotarget

Vol 4, No 6

June 2013

View Archive »

Order a Reprint

About The Cover

Image of a late stage tumor from an RbTKO mouse showing anterior chamber invasion, see Benavente et al.

Table of Contents

Editorial

LDH-A Acetylation: Implication in Cancer

LDH-A Acetylation: Implication in Cancer

https://doi.org/10.18632/oncotarget.1007

Di Zhao, Yue Xiong, Qun-Ying Lei,  and Kun-Liang Guan
802-803
PDF  |  HTML  |  Order a Reprint

Phenylbutyrate increases activity of pyruvate dehydrogenase complex.

Phenylbutyrate increases activity of pyruvate dehydrogenase complex.

https://doi.org/10.18632/oncotarget.1000

Rosa Ferriero,  and Nicola Brunetti-Pierri
804-805
PDF  |  HTML  |  Order a Reprint

Necdin, a p53 target gene, in stem cells

Necdin, a p53 target gene, in stem cells

https://doi.org/10.18632/oncotarget.997

Takashi Asai, Yan Liu,  and Stephen D Nimer
806-807
PDF  |  HTML  |  Order a Reprint

STAT5b in LGL leukemia – a novel therapeutic target?

STAT5b in LGL leukemia – a novel therapeutic target?

https://doi.org/10.18632/oncotarget.1035

Hanna L. M. Rajala,  and Satu Mustjoki
808-809
PDF  |  HTML  |  Order a Reprint

Mouse model resembling human lung cancer

Mouse model resembling human lung cancer

https://doi.org/10.18632/oncotarget.1017

Zuoxiang Xiao, Qun Jiang, Jami Willette-Brown,  and Yinling Hu
810-811
PDF  |  HTML  |  Order a Reprint

Single circulating tumor cell sequencing for monitoring

Single circulating tumor cell sequencing for monitoring

https://doi.org/10.18632/oncotarget.1026

Martina Auer, Ellen Heitzer, Peter Ulz, Jochen B. Geigl,  and Michael R Speicher
812-813
PDF  |  HTML  |  Order a Reprint

Editorial Broadcast

Germline Counterparts of Oncogenic Mutations: Who Gives a JAK?

Germline Counterparts of Oncogenic Mutations: Who Gives a JAK?

https://doi.org/10.18632/oncotarget.1105

Adam J Mead, Stefan N Constantinescu,  and Sten Eirik W Jacobsen
814-815
PDF  |  HTML  |  Order a Reprint

Research Papers

Targeting HSF1 sensitizes cancer cells to HSP90 inhibition

Targeting HSF1 sensitizes cancer cells to HSP90 inhibition

https://doi.org/10.18632/oncotarget.991

Yaoyu Chen, Jinyun Chen, Alice Loo, Savina Jaeger, Linda Bagdasarian, Jianjun Yu, Franklin Chung, Joshua Korn, David Ruddy, Ribo Guo, Margaret Mclaughlin, Fei Feng, Ping Zhu, Frank Stegmeier, Raymond Pagliarini, Dale Porter,  and Wenlai Zhou
816-829
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Pharmacologic targeting of the PI3K/mTOR pathway controls release of angioregulators from primary human acute myeloid leukemia cells and their neighboring stromal cells

Pharmacologic targeting of the PI3K/mTOR pathway controls release of angioregulators from primary human acute myeloid leukemia cells and their neighboring stromal cells

https://doi.org/10.18632/oncotarget.971

Håkon Reikvam, Ina Nepstad, Øystein Bruserud,  and Kimberley Joanne Hatfield
830-843
Abstract  |  PDF  |  HTML  |  Order a Reprint

Cross-species genomic and epigenomic landscape of retinoblastoma

Cross-species genomic and epigenomic landscape of retinoblastoma

https://doi.org/10.18632/oncotarget.1051

Claudia A. Benavente, Justina D. McEvoy, David Finkelstein, Lei Wei, Guolian Kang, Yong-Dong Wang, Geoffrey Neale, Susan Ragsdale, Virginia Valentine, Armita Bahrami, Jamshid Temirov, Stanley Pounds, Jinghui Zhang,  and Michael A. Dyer
844-859
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia

Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia

https://doi.org/10.18632/oncotarget.1018

Yin Tong, Liangshun You, Hui Liu, Lu Li, Haitao Meng, Qijun Qian,  and Wenbin Qian
860-874
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

pRb controls Estrogen Receptor alpha protein stability and activity

pRb controls Estrogen Receptor alpha protein stability and activity

https://doi.org/10.18632/oncotarget.1036

Isabella Caligiuri, Giuseppe Toffoli, Antonio Giordano,  and Flavio Rizzolio
875-883
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Germline PTPRD Mutations in Ewing Sarcoma: Biologic and Clinical Implications

Germline PTPRD Mutations in Ewing Sarcoma: Biologic and Clinical Implications

https://doi.org/10.18632/oncotarget.1021

Yunyun Jiang, Filip Janku, Vivek Subbiah, Laura S. Angelo, Aung Naing, Peter M. Anderson, Cynthia E. Herzog, Siqing Fu, Robert S. Benjamin,  and Razelle Kurzrock
884-889
Abstract  |  PDF  |  HTML  |  Order a Reprint

Thymoma Patients Treated in a Phase I Clinic at MD Anderson Cancer Center: Responses to mTOR Inhibitors and Molecular Analyses

Thymoma Patients Treated in a Phase I Clinic at MD Anderson Cancer Center: Responses to mTOR Inhibitors and Molecular Analyses

https://doi.org/10.18632/oncotarget.1015

Jennifer J. Wheler, David Hong, Stephen G. Swisher, Gerald S. Falchook, Apostolia Maria Tsimberidou, Thorunn Helgason, Aung Naing, Bettzy Stephen, Filip Janku, Philip J. Stephens, Roman Yelensky,  and Razelle Kurzrock
890-898
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Myeloablative Anti-CD20 Radioimmunotherapy +/- High-Dose Chemotherapy Followed by Autologous Stem Cell Support for Relapsed/Refractory B-Cell Lymphoma Results in Excellent Long-Term Survival

Myeloablative Anti-CD20 Radioimmunotherapy +/- High-Dose Chemotherapy Followed by Autologous Stem Cell Support for Relapsed/Refractory B-Cell Lymphoma Results in Excellent Long-Term Survival

https://doi.org/10.18632/oncotarget.1037

Julia Y. Wagner, Kathleen Schwarz, Susanne Schreiber, Burkhard Schmidt, Hans-Jürgen Wester, Markus Schwaiger, Christian Peschel, Christoph von Schilling, Klemens Scheidhauer,  and Ulrich Keller
899-910
Abstract  |  PDF  |  HTML  |  Order a Reprint

Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism

Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism

https://doi.org/10.18632/oncotarget.1066

Brigitte Sola, Marc Poirot, Philippe de Medina, Sophie Bustany, Véronique Marsaud, Sandrine Sivente-Poirot,  and Jack-Michel Renoir
911-922
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Acetylation of the Cell-Fate Factor Dachshund Determines p53 Binding and Signaling Modules in Breast Cancer

Acetylation of the Cell-Fate Factor Dachshund Determines p53 Binding and Signaling Modules in Breast Cancer

https://doi.org/10.18632/oncotarget.1094

Ke Chen, Kongming Wu, Michael Gormley, Adam Ertel, Wei Zhang, Jie Zhou, Gabriele DiSante, Zhiping Li, Hallgeir Rui, Andrew A. Quong, Steven B. McMahon, Haiteng Deng, Michael P. Lisanti, Chenguang Wang,  and Richard G. Pestell
923-935
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5

Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5

https://doi.org/10.18632/oncotarget.1108

Huabo Wang, Jay Chauhan, Angela Hu, Kelsey Pendleton, Jeremy L. Yap, Philip E. Sabato, Jace W. Jones, Mariarita Perri, Jianshi Yu, Erika Cione, Maureen A. Kane, Steven Fletcher,  and Edward V. Prochownik
936-947
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint


Copyright © 2017 Impact Journals
Impact Journals is a registered trademark of Impact Journals, LLC